A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Huadong Medicine Co. Ltd. recently revealed data from in vitro and preclinical studies performed to evaluate the efficacy and pharmacokinetic, safety and tolerability profiles of a dual glucagon-like ...

Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...

Scientists have uncovered critical differences between how innate-like T cells mature in humans and mice. Early in life, most innate-like T cells in the human thymus aren't able to use all of their ...

Men and women don’t experience pain the same way. Give someone an electric shock; bind a tourniquet tighter and tighter ...

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of photoimmunotherapy: depletion of PD-L1 expressing tumor cells and depletion ...

Researchers at Duke-NUS Medical School have discovered that interleukin-11 (IL11) plays a crucial role in the aging process, ...

AUSTIN, Texas, Sept. 20, 2024 /PRNewswire/ -- Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

The option gives Glaukos exclusive global license agreements on pre-agreed terms, including upfront and milestone payments ...